APA (7th ed.) Citation

Pearson, A., Jin, W., Mellon, E., Frakes, J., Strom, T., Springett, G., . . . Hoffe, S. (2016). Post-Stereotactic Body Radiation Therapy (SBRT) Neutrophil-to-Lymphocyte Ratio (NLR) in Patients With Borderline Resectable Pancreatic Cancer (BRPC) May Be a Prognostic Biomarker. International Journal of Radiation Oncology, Biology, Physics, 96, E153. https://doi.org/10.1016/j.ijrobp.2016.06.974

Chicago Style (17th ed.) Citation

Pearson, A.L, et al. "Post-Stereotactic Body Radiation Therapy (SBRT) Neutrophil-to-Lymphocyte Ratio (NLR) in Patients With Borderline Resectable Pancreatic Cancer (BRPC) May Be a Prognostic Biomarker." International Journal of Radiation Oncology, Biology, Physics 96 (2016): E153. https://doi.org/10.1016/j.ijrobp.2016.06.974.

MLA (9th ed.) Citation

Pearson, A.L, et al. "Post-Stereotactic Body Radiation Therapy (SBRT) Neutrophil-to-Lymphocyte Ratio (NLR) in Patients With Borderline Resectable Pancreatic Cancer (BRPC) May Be a Prognostic Biomarker." International Journal of Radiation Oncology, Biology, Physics, vol. 96, 2016, p. E153, https://doi.org/10.1016/j.ijrobp.2016.06.974.